Why your cardiologist may prescribe semaglutide (Wegovy), Yale Medicine (2024) Once-weekly semaglutide in adults with overweight or obesity, The New England Journal of Medicine (2021) Controlled-release phentermine/topiramate in severely obese adults: A randomized controlled trial (EQUIP), Obesity (2012) Label: Qsymia phentermine and topiramate capsule, extended release, DailyMed (2023) Label: Wegovy semaglutide injection, solution, DailyMed (2024) Semaglutide, StatPearls (2024) Qsymia highlights of prescribing information, Vivus LLC (2023) Wegovy highlights of prescribing information, Novo Nordisk Inc
Compounded medications are prepared within regulated pharmacy environments, following defined standards for sourcing, preparation, and quality controls
As a class, the DPP-4 inhibitors are weight neutral, causing neither weight gain nor weight loss
Your cost remains $149/month regardless of external supply constraints